PASG
Income statement / Annual
Last year (2024), Passage Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Passage Bio, Inc.'s net income was -$64.77 M.
See Passage Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$3.72 M
|
$3.68 M
|
$1.54 M
|
$800,000.00
|
$134,000.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$3.72 M
|
-$3.68 M
|
-$1.54 M
|
-$800,000.00
|
-$134,000.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$40.18 M
|
$61.42 M
|
$86.05 M
|
$117.67 M
|
$81.79 M
|
$29.74 M
|
$9.17 M
|
| General & Administrative Expenses |
$24.99 M
|
$41.58 M
|
$49.34 M
|
$60.06 M
|
$30.11 M
|
$6.95 M
|
$928,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$24.99 M
|
$41.58 M
|
$49.34 M
|
$60.06 M
|
$30.11 M
|
$6.95 M
|
$928,000.00
|
| Other Expenses |
$0.00
|
$5.39 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$65.17 M
|
$108.39 M
|
$135.39 M
|
$177.73 M
|
$111.90 M
|
$36.69 M
|
$10.10 M
|
| Cost And Expenses |
$0.00
|
$108.39 M
|
$135.39 M
|
$177.73 M
|
$111.90 M
|
$36.69 M
|
$10.10 M
|
| Interest Income |
$0.00
|
$5.60 M
|
$2.27 M
|
$343,000.00
|
$670,000.00
|
$696,000.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$2.27 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$3.72 M
|
$3.68 M
|
$1.54 M
|
$800,000.00
|
$134,000.00
|
$10.10 M
|
| EBITDA |
-$70.40 M |
-$98.34 M |
-$138.39 M |
-$185.73 M |
-$112.90 M |
-$36.56 M |
-$12.77 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$5.63 M
|
$6.33 M
|
$2.27 M
|
$343,000.00
|
$670,000.00
|
-$8.45 M
|
$696,000.00
|
| Income Before Tax |
-$64.77 M
|
-$102.06 M
|
-$136.13 M
|
-$185.39 M
|
-$112.23 M
|
-$45.63 M
|
-$12.77 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$731,000.00
|
$6.11 M
|
-$470,000.00
|
$8.95 M
|
-$696,000.00
|
| Net Income |
-$64.77 M
|
-$102.06 M
|
-$136.86 M
|
-$191.50 M
|
-$111.76 M
|
-$54.58 M
|
-$12.77 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.07 |
-1.86 |
-2.51 |
-3.59 |
-2.89 |
-1.19 |
-0.53 |
| EPS Diluted |
-1.07 |
-1.86 |
-2.51 |
-3.59 |
-2.89 |
-1.19 |
-0.53 |
| Weighted Average Shares Out |
$60.41 M
|
$54.74 M
|
$54.43 M
|
$53.34 M
|
$38.62 M
|
$45.80 M
|
$23.96 M
|
| Weighted Average Shares Out Diluted |
$60.41 M
|
$54.74 M
|
$54.43 M
|
$53.34 M
|
$38.62 M
|
$45.80 M
|
$23.96 M
|
| Link |
|
|
|
|
|
|
|
